Becker's Healthcare October 25, 2023
Noah Schwartz

Moderna is partnering with artificial intelligence-focused precision medicine company Caris Life Science to support Moderna’s oncology initiatives.

Through the multiyear partnership, Moderna will use Caris’ library of deidentified data to advance the company’s oncology pipeline. Additionally, the partnership will focus on facilitating clinical trial design, discovering new biomarkers and characterizing resistance mechanisms, according to an Oct. 24 Caris news release.

Financial terms of the partnership were not disclosed.

“We are thrilled to partner...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Precision Medicine, Technology, Trends
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article